An App-based Instructional Platform to Improve Eye Drop Recall - Trial NCT06045390
Access comprehensive clinical trial information for NCT06045390 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Francisco and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of California, San Francisco
Timeline & Enrollment
N/A
Oct 01, 2023
Sep 01, 2024
Primary Outcome
Percentage accuracy of drop regimen recall
Summary
The goal of this interventional study is to assess whether an in-office, language-concordant
 instructional app improves drop regimen recall in a population of glaucoma patients who are
 on multi-drop regimens.
 
 Participants will be divided into two groups -- those who use the app and those who do not.
 The app will have narrated information regarding the drop regimen, a quiz to test
 understanding of the regimen, and will enable a graphical printout of the eye drops and
 schedule.
 
 At one month, both groups will be assessed on their eye drop regimen recall.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06045390
Non-Device Trial